DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

by Ettrich, Thomas J., Perkhofer, Lukas, von Wichert, Goetz, Gress, Thomas M., Michl, Patrick, Hebart, Holger F., Büchner-Steudel, Petra, Geissler, Michael, Muche, Rainer, Danner, Bettina, Kächele, Volker, Berger, Andreas W., Güthle, Melanie, Seufferlein, Thomas
Published 2016